Application 207479
- Type
- ANDA
- Sponsor
- SCIEGEN PHARMS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 150MG | No | No |
| 002 | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 300MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207479-001 | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | |
| A207479-002 | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A207479-001 | AB3 |
| A207479-002 | AB3 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A207479-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A207479-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207479-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A207479-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207479-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207479-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207479-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A207479-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207479-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207479-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207479-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207479-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207479-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207479-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207479-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207479-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207479-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207479-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207479-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207479-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A207479-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A207479-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207479-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207479-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207479-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207479-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207479-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207479-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A207479-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A207479-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207479-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207479-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A207479-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A207479-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A207479-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A207479-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A207479-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A207479-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A207479-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | A207479-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | bb7c543d1eb4… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A207479-001 | AB3 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A207479-002 | AB3 | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A207479-001 | AB3 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A207479-002 | AB3 | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207479-001 | AB3 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207479-002 | AB3 | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A207479-001 | AB3 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A207479-002 | AB3 | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207479-001 | AB3 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207479-002 | AB3 | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207479-001 | AB3 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207479-002 | AB3 | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207479-001 | AB3 | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207479-002 | AB3 | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207479-001 | AB3 | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207479-002 | AB3 | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207479-001 | AB3 | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207479-002 | AB3 | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207479-001 | AB3 | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207479-002 | AB3 | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A207479-001 | AB3 | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A207479-002 | AB3 | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207479-001 | AB3 | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207479-002 | AB3 | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207479-001 | AB3 | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207479-002 | AB3 | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207479-001 | AB3 | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207479-002 | AB3 | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A207479-001 | AB3 | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A207479-002 | AB3 | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207479-001 | AB3 | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207479-002 | AB3 | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A207479-001 | AB3 | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A207479-002 | AB3 | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A207479-001 | AB3 | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A207479-002 | AB3 | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A207479-001 | AB3 | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A207479-002 | AB3 | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A207479-001 | AB3 | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A207479-002 | AB3 | 1 | bb7c543d1eb4… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | REMEDYREPACK INC. | 4cc3327b-92c5-4667-ae16-3e95eafcf4d8 | 2026-07-27 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 30c370c2-f2b7-4335-ba55-e8c8f4059092 | 2026-07-24 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | Bryant Ranch Prepack | 8499470a-8d01-4348-b67b-8f49728031cb | 2026-06-10 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | Bryant Ranch Prepack | cefaaa17-f79a-4ba6-8f97-a59f60e07b75 | 2026-05-28 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | REMEDYREPACK INC. | 0cd6e0e2-6b2c-4e0d-b5b2-ebfe0d5e31c4 | 2026-05-05 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | Bryant Ranch Prepack | 96e78f74-fad0-4ae1-9e68-55e4c6ab2d60 | 2026-04-09 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 63629-8476 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | Bryant Ranch Prepack | 03b1b0a9-0aa2-4039-acce-68ca54abaae4 | 2026-04-08 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 63629-8474 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | Bryant Ranch Prepack | a5417808-f767-48fc-9f5d-c1aeee4e57c3 | 2026-04-08 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 63629-8475 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | Bryant Ranch Prepack | a7553281-be90-47e3-8d2b-b027f6d18d3a | 2026-03-31 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | RADHA PHARMACEUTICALS, INC. | 16a788ff-8bd5-4f70-a3fd-a89db019e435 | 2026-02-03 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 77771-144 77771-145 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | ScieGen Pharmaceuticals,Inc. | 05f82eca-cc87-4580-acd7-e6491c651881 | 2026-02-02 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 50228-145 50228-144 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | Northwind Health Company, LLC | 4ddf6ba2-c020-7912-e063-6394a90a7964 | 2026-01-12 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 459bd1c9-d7a5-8bc9-e063-6394a90a8ecd | 2025-12-10 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride | BUPROPION HYDROCHLORIDE | A-S Medication Solutions | 722650d8-5ee4-48ba-9827-7c86b1283522 | 2025-10-16 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride | BUPROPION HYDROCHLORIDE | A-S Medication Solutions | 16ffe2ac-4f71-4843-99df-611f53c2f3cd | 2025-10-16 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | Advanced Rx of Tennessee, LLC | 3d826804-6427-aae1-e063-6394a90a6593 | 2025-08-29 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | Quality Care Products, LLC | 57a9f4d3-0c41-4978-b81e-cf3059bc8c42 | 2024-12-19 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | A-S Medication Solutions | 0ac739de-ad59-4882-810e-f52db22ac96f | 2024-10-16 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | A-S Medication Solutions | d6efb695-c439-48d7-a155-5c661a5049af | 2024-10-16 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride | BUPROPION HYDROCHLORIDE | Cipla USA., Inc. | 0abd64f7-5142-48f6-a487-3f5bdc3400de | 2023-10-19 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 43598-655 | Bupropion Hydrochloride | bupropion hydrochloride | Dr Reddys Laboratories Inc | ANDA | Current |
| 43598-655 | Bupropion Hydrochloride | bupropion hydrochloride | Dr Reddys Laboratories Inc | ANDA | Current |
| 43598-655 | Bupropion Hydrochloride | bupropion hydrochloride | Dr Reddys Laboratories Inc | ANDA | Current |
| 43598-655 | Bupropion Hydrochloride | bupropion hydrochloride | Dr Reddys Laboratories Inc | ANDA | Current |
| 43598-655 | Bupropion Hydrochloride | bupropion hydrochloride | Dr Reddys Laboratories Inc | ANDA | Current |
| 43598-656 | Bupropion Hydrochloride | bupropion hydrochloride | Dr Reddys Laboratories Inc | ANDA | Current |
| 43598-656 | Bupropion Hydrochloride | bupropion hydrochloride | Dr Reddys Laboratories Inc | ANDA | Current |
| 43598-656 | Bupropion Hydrochloride | bupropion hydrochloride | Dr Reddys Laboratories Inc | ANDA | Current |
| 43598-656 | Bupropion Hydrochloride | bupropion hydrochloride | Dr Reddys Laboratories Inc | ANDA | Current |
| 43598-656 | Bupropion Hydrochloride | bupropion hydrochloride | Dr Reddys Laboratories Inc | ANDA | Current |
| 50228-144 | Bupropion Hydrochloride | bupropion hydrochloride | ScieGen Pharmaceuticals,Inc. | ANDA | Current |
| 50228-144 | Bupropion Hydrochloride | bupropion hydrochloride | ScieGen Pharmaceuticals,Inc. | ANDA | Current |
| 50228-144 | Bupropion Hydrochloride | bupropion hydrochloride | ScieGen Pharmaceuticals,Inc. | ANDA | Current |
| 50228-144 | Bupropion Hydrochloride | bupropion hydrochloride | ScieGen Pharmaceuticals,Inc. | ANDA | Current |
| 50228-144 | Bupropion Hydrochloride | bupropion hydrochloride | ScieGen Pharmaceuticals,Inc. | ANDA | Current |
| 50228-144 | Bupropion Hydrochloride | bupropion hydrochloride | ScieGen Pharmaceuticals,Inc. | ANDA | Current |
| 50228-145 | Bupropion Hydrochloride | bupropion hydrochloride | ScieGen Pharmaceuticals,Inc. | ANDA | Current |
| 50228-145 | Bupropion Hydrochloride | bupropion hydrochloride | ScieGen Pharmaceuticals,Inc. | ANDA | Current |
| 50228-145 | Bupropion Hydrochloride | bupropion hydrochloride | ScieGen Pharmaceuticals,Inc. | ANDA | Current |
| 50228-145 | Bupropion Hydrochloride | bupropion hydrochloride | ScieGen Pharmaceuticals,Inc. | ANDA | Current |
| 50228-145 | Bupropion Hydrochloride | bupropion hydrochloride | ScieGen Pharmaceuticals,Inc. | ANDA | Current |
| 50228-145 | Bupropion Hydrochloride | bupropion hydrochloride | ScieGen Pharmaceuticals,Inc. | ANDA | Current |
| 63629-8474 | Bupropion Hydrochloride | bupropion hydrochloride | Bryant Ranch Prepack | ANDA | Current |
| 63629-8474 | Bupropion Hydrochloride | bupropion hydrochloride | Bryant Ranch Prepack | ANDA | Current |
| 63629-8474 | Bupropion Hydrochloride | bupropion hydrochloride | Bryant Ranch Prepack | ANDA | Current |
| 63629-8475 | Bupropion Hydrochloride | bupropion hydrochloride | Bryant Ranch Prepack | ANDA | Current |
| 63629-8475 | Bupropion Hydrochloride | bupropion hydrochloride | Bryant Ranch Prepack | ANDA | Current |
| 63629-8475 | Bupropion Hydrochloride | bupropion hydrochloride | Bryant Ranch Prepack | ANDA | Current |
| 63629-8476 | Bupropion Hydrochloride | bupropion hydrochloride | Bryant Ranch Prepack | ANDA | Current |
| 63629-8476 | Bupropion Hydrochloride | bupropion hydrochloride | Bryant Ranch Prepack | ANDA | Current |
| 63629-8476 | Bupropion Hydrochloride | bupropion hydrochloride | Bryant Ranch Prepack | ANDA | Current |
| 77771-144 | Bupropion Hydrochloride | bupropion hydrochloride | RADHA PHARMACEUTICALS, INC. | ANDA | Current |
| 77771-145 | Bupropion Hydrochloride | bupropion hydrochloride | RADHA PHARMACEUTICALS, INC. | ANDA | Current |